Estimation of standardized real-time fatality rate for ongoing epidemics

Author:

Qu Yuanke,Lee Chun YinORCID

Abstract

Background The fatality rate is a crucial metric for guiding public health policies during an ongoing epidemic. For COVID-19, the age structure of the confirmed cases changes over time, bringing a substantial impact on the real-time estimation of fatality. A ‘spurious decrease’ in fatality rate can be caused by a shift in confirmed cases towards younger ages even if the fatalities remain unchanged across different ages. Methods To address this issue, we propose a standardized real-time fatality rate estimator. A simulation study is conducted to evaluate the performance of the estimator. The proposed method is applied for real-time fatality rate estimation of COVID-19 in Germany from March 2020 to May 2022. Findings The simulation results suggest that the proposed estimator can provide an accurate trend of disease fatality in all cases, while the existing estimator may convey a misleading signal of the actual situation when the changes in temporal age distribution take place. The application to Germany data shows that there was an increment in the fatality rate at the implementation of the ‘live with COVID’ strategy. Conclusions As many countries have chosen to coexist with the coronavirus, frequent examination of the fatality rate is of paramount importance.

Publisher

Public Library of Science (PLoS)

Reference45 articles.

1. The Guardian. US experts question whether counting COVID cases is still the right approach; 2022. https://www.theguardian.com/us-news/2022/jan/01/us-covid-case-counts-omicron.

2. U.S. News. COVID case counts may be losing importance amid Omicron; 2022. https://www.usnews.com/news/health-news/articles/2022-01-04/covid-case-counts-may-be-losing-importance-amid-omicron.

3. Early epidemiological assessment of the transmission potential and virulence of coronavirus disease 2019 (COVID-19) in Wuhan City, China, January–February, 2020;K Mizumoto;BMC Medicine,2020

4. Estimating risk for death from coronavirus disease, China, January–February 2020;K Mizumoto;Emerging Infectious Diseases,2020

5. Assessing the severity of the novel influenza A/H1N1 pandemic;T Garske;BMJ,2009

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3